Michael J. Sailor, PhD
FNAI (USA), FRSC (UK)
Michael J. Sailor is Distinguished Professor of Chemistry and Biochemistry at the University of California, San Diego, Director of the NSF-funded UC San Diego Materials Research Science and Engineering Center (MRSEC), and co-Director of the UC San Diego Institute for Materials Discovery and Design. He holds Affiliate Appointments in the Bioengineering, the Nanoengineering, and the Materials Science and Engineering programs at UC San Diego. Other appointments include: Invited Professor, CNRS Institut Charles Gerhardt in Montpellier, France (2012); Visiting Professor, High Level Talent Program, Key Laboratory of Organosilicon Chemistry and Material Technology, Hangzhou Normal University, China (2018-2020); and Visiting Professor, Zhejiang University, China (2019-2020).
Trained as a chemist, Sailor received a BS degree from Harvey Mudd College in 1983 and a PhD degree from Northwestern University in 1988. He began his academic career at UC San Diego in 1990, was promoted to Associate Professor in 1994, to Full Professor in 1996, and to Distinguished Professor in 2015.
He has supervised more than 160 undergraduate, graduate, and post-doctoral students at UC San Diego. He has published more than 300 peer-reviewed papers, 7 book chapters, 1 book, and he holds 29 U.S. patents and 6 international patents. He was named a Highly Cited Researcher by Clarivate Analytics in 2018 and in 2019. He has a citation h-index of 91 (Google Scholar).
Sailor serves on the editorial boards of the journals Nanoscale Horizons, ACS Nano, Applied Physics Letters, and Advanced Materials, and he is an Associate Editor of the journal ACS Sensors. He has served on several scientific advisory boards including the United States Air Force,Illumina, Matrix Industries, Nanovision Biosciences, Pacific Integrated Energy, TruTags, and Well-Healthcare Technologies, and he co-founded Spinnaker Biosciences and Impilo Therapeutics.
Sailor is an elected Fellow of the American Association for the Advancement of Science, the Royal Society of Chemistry, and the National Academy of Inventors.(updated July 2020)
Prof Sailor has held appointments at the following institutions: as a “High-Level Talent” at the Key Laboratory of Organosilicon Chemistry and Material Technology of Hangzhou Normal University, China (2017-2020); as a Guest Professor at Zhejiang University, China (2019-2020); and as an Invited Professor at the CNRS Institut Charles Gerhardt in Montpellier, France (2012). He is a scientific founder of Spinnaker Biosciences, Inc., a member of the Board of Directors, and has an equity interest in the company; he is a scientific founder of Impilo Therapeutics, Inc., a member of the Board of Directors, and has an equity interest in the company. He has a financial interest (as a consultant, shareholder, scientific advisor, and/or board member) with NanoVision Bio, Pacific Integrated Energy, Matrix Technologies, Illumina, Bejing ITEC Technologies, Well-Healthcare Technologies, and TruTag Technologies. These relationships have been disclosed for conflict of interest management and the terms of the arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.